Ohio‐Based Investors Back Naples Medical Tech Firm with $15 M Infusion

Catalyst OrthoScience, a Naples-headquartered medical-device company focused on shoulder-arthroplasty solutions, announced that it has raised $15 million in a new round of combined equity and debt financing.

Based in Naples, the company was founded in 2014 and specializes in simplifying shoulder implant procedures through surgeon-centric innovation.

The new funding round was led by Ohio-based RC Capital (Cincinnati) along with participation from Mutual Capital Partners of Cleveland, physician-investor Derace Schaffer, and Western Alliance Bank of Phoenix.

This latest round follows a $20 million fundraising effort in 2024, bringing the company’s financing over the last two years to at least $35 million.

Why this matters locally:

• For Naples and Collier County, this injection of capital reinforces the region’s growing presence in medical-technology and device innovation—beyond the more traditional tourism and real-estate economy.

• As Catalyst advances clinical and commercial programs, the company may drive job growth, attract ancillary medical-supply firms and enhance Naples’ reputation as a med-tech hub.

• For real-estate, service‐business and hospitality sectors: The presence of growth-oriented tech companies provides diversification and may broaden non-seasonal workforce demand (office space, housing, amenities).

What to watch:

• Catalyst’s next milestone will be how it deploys the funds—expanding clinical trials, scaling manufacturing, or launching new implant systems.

• Whether the company stays anchored in Naples or expands operations (manufacturing, R&D) elsewhere will affect local employment and commercial real-estate usage.

• Opportunities for local partnerships—vendors, suppliers, logistic services—that support med-tech firms could emerge as Catalyst scales.